Chongqing Taiji Industry(Group) Co.,Ltd (SHSE:600129) agreed to acquire Chongqing Chinese Medicinal Materials Co., Ltd. from Chongqing Taiji Group Co., Ltd. for CNY 24.386 million on January 16, 2023. Chongqing Chinese Medicinal Materials Co., Ltd. reported total assets of CNY 178.29 million, operating income is CNY 203.11 million, net profit is CNY 2.79 million, and net assets of CNY 19.64 million on December 31, 2022. Chongqing Chinese Medicinal Materials Co., Ltd. board approved the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
37.61 CNY | -0.45% | +3.61% | -19.05% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.05% | 2.9B | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+3.54% | 283B | |
+15.89% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B |
- Stock Market
- Equities
- 600129 Stock
- News Chongqing Taiji Industry(Group) Co.,Ltd
- Chongqing Taiji Industry(Group) Co.,Ltd agreed to acquire Chongqing Chinese Medicinal Materials Co., Ltd. from Chongqing Taiji Group Co., Ltd. for CNY 24.386 million.